COLAZAL Safety Questions, COLAZAL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about COLAZAL. Our extensive database of COLAZAL adverse events and COLAZAL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about COLAZAL
COLAZAL Safety Reports
Total COLAZAL reports: 35.COLAZAL FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 23.
Take COLAZAL Side Effects Survey or Share Your COLAZAL Story. COLAZAL Usage.
Consumer or non-health professional from UNITED KINGDOM reported COLAZAL problem on Jan 26, 2007. Male patient was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: renal failure acute. COLAZAL dosage: 6.75 GM (750 MG, 9 IN 1 D), ORAL. During the same period patient was treated with LISINOPRIL, ISOPHANE INSULIN, DILTIAZEM, ACETYLSALICYLIC ACID SRT, PREDNISOLONE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Feb 02, 2007. Male patient, 47 years of age, weighting 236.0 lb, was diagnosed with colitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anosmia, encephalitis, fluid retention, skin lesion, testicular disorder, weight increased. COLAZAL dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported COLAZAL problem on Feb 21, 2007. Female patient, 57 years of age, weighting 165.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: chromaturia, faeces discoloured. COLAZAL dosage: 2250MG TID PO. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 69 years of age, weighting 264.0 lb, was diagnosed with colitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, heart rate irregular, pain. COLAZAL dosage: 750MG 3 PER DAY. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on Mar 20, 2007. Male patient, 47 years of age, weighting 236.0 lb, was diagnosed with colitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anosmia, encephalitis, mental status changes, skin lesion, testicular disorder, weight increased. COLAZAL dosage: unknown. During the same period patient was treated with ADDERALL. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2007. Male patient, 22 years of age, weighting 240.0 lb, was diagnosed with crohn's disease and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: anxiety, aphasia, headache, hypocalcaemia, respiratory tract infection, tremor, vomiting. COLAZAL dosage: THREE 750MG CAPSULES, THREE TIMES DAILY (750 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ASACOL, VITAMINS, PROTONIX, MERCAPTOPURINE, REMICADE, ZANTAC, LEXAPRO, VITAMIN D. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on Mar 30, 2007. Male patient, 32 years of age, weighting 257.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: angioedema, dysphagia, erythema, pruritus, white blood cell count increased. COLAZAL dosage: 7500 MG (3750 MG, 2 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Feb 14, 2007. Female patient, 41 years of age, weighting 135.0 lb, was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, lip pain, lip swelling, pancreatitis, rash. COLAZAL dosage: 750 MG, ORAL. During the same period patient was treated with PENTASA. Patient was hospitalized and became disabled. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on Apr 06, 2007. Female patient, 41 years of age, weighting 135.0 lb, was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, lip pain, lip swelling, pancreatitis, rash. COLAZAL dosage: 750 MG, ORAL. During the same period patient was treated with PENTASA. Patient was hospitalized and became disabled. Patient recovered.
COLAZAL problem was reported by a Health Professional from UNITED KINGDOM on May 18, 2007. Male patient, 38 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: chest pain, electrocardiogram change, myocarditis, troponin increased. COLAZAL dosage: unknown. During the same period patient was treated with ASACOL, PREDNISLONE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported COLAZAL problem on May 18, 2007. Male patient, 38 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: electrocardiogram t wave inversion, myocarditis, troponin i increased. COLAZAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, MESALAZINE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from ITALY on May 30, 2007. Male patient, 31 years of age, was diagnosed with proctocolitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, angioedema, dysphagia, toxic epidermal necrolysis. COLAZAL dosage: unknown. During the same period patient was treated with SULFASALAZINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED KINGDOM reported COLAZAL problem on June 13, 2007. Male patient, 44 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: leishmaniasis, pancytopenia. COLAZAL dosage: unknown. During the same period patient was treated with PARACETAMOL. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Female patient, 24 years of age, weighting 130.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: blister, emotional disorder, pain, refusal of treatment by patient, scab, scar, skin discolouration, ulcer. COLAZAL dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported COLAZAL problem on July 31, 2006. Female patient, 69 years of age, weighting 138.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, blood calcium increased, blood parathyroid hormone decreased, frequent bowel movements, lipase increased. COLAZAL dosage: unknown. During the same period patient was treated with CLONAZEPAM, OXYGEN. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Male patient, 44 years of age, weighting 167.0 lb, was diagnosed with colitis ulcerative, scrotal infection, scrotal pain and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal tenderness, activated partial thromboplastin time prolonged, ascites, azotaemia, blood albumin decreased, dialysis, groin pain. COLAZAL dosage: 300MG/TID (4 PILLS/TID), ORAL. During the same period patient was treated with IMURAN, REMICADE, DOXYCYCLINE, EXTRA STRENGTH TYLENOL, ADVIL, ALEVE. Patient was hospitalized. Patient died on 06/14/2006.
Health Professional from UNITED STATES reported COLAZAL problem on Sept 20, 2006. Female patient, 36 years of age, weighting 94.00 lb, was diagnosed with crohn's disease and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, clostridial infection, colitis ulcerative, nausea, white blood cell count increased. COLAZAL dosage: unknown. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Male patient, child 9 years of age, weighting 75.00 lb, was diagnosed with colitis ulcerative, crohn's disease and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: educational problem, growth retardation, weight gain poor. COLAZAL dosage: 750 MG 3X DAILY PO. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported COLAZAL problem on Sept 29, 2006. Male patient, 17 years of age, weighting 157.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: oesophageal ulcer. COLAZAL dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Sept 28, 2006. Male patient, 69 years of age, weighting 210.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest pain, heart rate increased, tremor. COLAZAL dosage: 2250 MG/TID (750 MG), ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported COLAZAL problem on Oct 17, 2006. Male patient was diagnosed with haemorrhage and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: arthritis, dyspnoea, feeling abnormal, lethargy. COLAZAL dosage: unknown. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Mar 21, 2006. Female patient was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. COLAZAL dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported COLAZAL problem on Dec 13, 2006. Male patient, 38 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: chest pain, electrocardiogram t wave inversion, myocarditis, troponin i increased. COLAZAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, MESALAZINE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Pharmacist from UNITED STATES on June 27, 2007. Female patient, 50 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative, condition aggravated. COLAZAL dosage: 6750 MG (2250 MG, 3 IN 1 D), ORAL. During the same period patient was treated with FOSAMAX. Patient recovered.
Physician from ITALY reported COLAZAL problem on July 06, 2007. Male patient, 31 years of age, weighting 154.3 lb, was diagnosed with proctocolitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, angioedema, aphthous stomatitis, disseminated intravascular coagulation, eosinophilia, leukocytosis, liver function test abnormal, lung infiltration, lymphadenopathy. COLAZAL dosage: unknown. During the same period patient was treated with SULFASALAZINE, PREDNISONE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on July 16, 2007. Male patient, 33 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: renal failure acute. COLAZAL dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on July 31, 2007. Male patient, 33 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: renal failure acute. COLAZAL dosage: 6.75 GM (2.25 MG,3 IN 1 D), ORAL. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 71 years of age, weighting 119.0 lb, was diagnosed with colitis microscopic and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: arthralgia, gait disturbance, musculoskeletal stiffness. COLAZAL dosage: 2250 MG (750 MG, 3 IN 1 D), ORAL, 750 MG (750 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PROPACET, LOVASTATIN, LEVOTHYROXINE, FOSAMAX, CHOLESTYRAMINE, AMITRIPTYLINE, PRILOSEC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported COLAZAL problem on Mar 05, 2007. Female patient, child 9 years of age, weighting 60.00 lb, was diagnosed with colitis and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. COLAZAL dosage: 2250 MG (750 MG,3 IN 1 D), ORAL. During the same period patient was treated with INSULIN, INSULIN LISPRO. Patient recovered.
COLAZAL problem was reported by a Physician from UNITED STATES on Sept 27, 2005. Female patient, 35 years of age, weighting 137.0 lb, was diagnosed with colitis ulcerative, crohn's disease and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. COLAZAL dosage: unknown. During the same period patient was treated with AZASAN, PENTASA, REMICADE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on Mar 23, 2006. Male patient, 19 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. COLAZAL dosage: unknown. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Pharmacist from UNITED STATES on May 01, 2006. Male patient, 78 years of age, weighting 198.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, sinusitis. COLAZAL dosage: unknown. During the same period patient was treated with MUCOLEX, SYNTHROID, DIOVAN, TOPROL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported COLAZAL problem on May 04, 2006. Female patient, 71 years of age, weighting 173.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. COLAZAL dosage: unknown. During the same period patient was treated with CANASA, ROWASA. Patient was hospitalized. Patient recovered.
COLAZAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient, 35 years of age, weighting 170.0 lb, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative. COLAZAL dosage: 2.25MG/TID,ORAL. During the same period patient was treated with PREDNISONE. Patient recovered.
Physician from UNITED STATES reported COLAZAL problem on Sept 19, 2007. Male patient, 33 years of age, was diagnosed with colitis ulcerative and was treated with COLAZAL. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial, renal failure acute. COLAZAL dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PRIMAL DIFFERENCE. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert